序号 |
标题 |
次数 |
作者 |
发布时间 |
69751 |
Propargyl-PEG1-CH2CO2tBu的应用领域 |
78 |
wyh |
2024-12-24 |
69752 |
Fmoc-8-amino-3,6-dioxaoctanoic acid CAS:166108-71-0 |
118 |
h |
2024-12-24 |
69753 |
Maleimide-NH-PEG16-CH2CH2COOPFP Ester |
80 |
zyl |
2024-12-24 |
69754 |
八乙基锌卟啉(OEPZn) |
98 |
WYQ |
2024-12-24 |
69755 |
NH2-PEG2-C2-Boc CAS:756525-95-8 |
78 |
h |
2024-12-24 |
69756 |
170908-81-3,DOTA mono-NHS ester,DOTA单-N-羟基琥珀酰亚胺酯,大环化合物 |
67 |
kx |
2024-12-24 |
69757 |
PDdB-Pfp,2101206-44-2,ADC试剂 |
86 |
hyy |
2024-12-24 |
69758 |
MAL-HA-OSu,ADC linker |
88 |
h |
2024-12-24 |
69759 |
Maleimide-PEG10-CH2CH2COOH 马来酰亚胺-十聚乙二醇-丙酸 |
86 |
zyl |
2024-12-24 |
69760 |
Fmoc-Ala-Ala-Asn-PABC-PNP CAS:1834516-06-1 |
74 |
h |
2024-12-24 |
69761 |
Hydroxy-PEG4-(CH2)2-Boc CAS:518044-32-1 |
81 |
h |
2024-12-24 |
69762 |
H2N-PEG7-OH cas:1425973-14-3 氨基-七聚乙二醇-羟基 |
67 |
zyl |
2024-12-24 |
69763 |
meso-5,10,15,20-四(4-磺酸基苯基)卟啉锰钠盐-NO配合物(TPPSNa—Mn-NO) |
79 |
WYQ |
2024-12-24 |
69764 |
Fmoc-NH-PEG2-CH2CH2COOH CAS:872679-70-4 |
80 |
h |
2024-12-24 |
69765 |
DOTA-Glu(cyclo(Arg-Gly-Asp-DPhe-Lys))2,大环配体 |
80 |
kx |
2024-12-24 |
69766 |
Maleimide-NH-PEG16-CH2CH2COOH 马来酰亚胺-NH-十六聚乙二醇-丙酸 |
70 |
zyl |
2024-12-24 |
69767 |
Hydroxy-PEG3-(CH2)2-Boc CAS:186020-66-6 |
115 |
h |
2024-12-24 |
69768 |
5-乙酰硫苯基-10,15,20-三苯基卟啉(AcS-TPP) |
76 |
WYQ |
2024-12-24 |
69769 |
HO-PEG10-CH2CH2COOH 羟基-十聚乙二醇-丙酸 |
74 |
zyl |
2024-12-24 |
69770 |
NO2-SPP CAS:663598-61-6 |
77 |
h |
2024-12-24 |
69771 |
Gd-EOB-DTPA,大环化合物 |
139 |
kx |
2024-12-24 |
69772 |
5,15-(4-氨基苯基)-10,20-苯基卟啉(TPP-NH2-2O) |
76 |
WYQ |
2024-12-24 |
69773 |
Bromo-PEG2-C2-azide CAS:530151-56-5 |
97 |
h |
2024-12-24 |
69774 |
Propargyl-PEG4-CH2CO2H,叠氮-四聚乙二醇-乙酸 |
64 |
wyh |
2024-12-24 |
69775 |
Fmoc-Val-Ala-PAB-OH CAS:1394238-91-5 |
116 |
h |
2024-12-24 |
69776 |
890409-85-5,抗体- 药物偶联物 |
88 |
hyy |
2024-12-24 |
69777 |
PEG6-(CH2CO2H)2,乙酸-五聚乙二醇-乙酸 |
81 |
wyh |
2024-12-24 |
69778 |
DOTA多肽分子探针,619300-53-7,DOTA NOC acetate,大环化合物 |
73 |
kx |
2024-12-24 |
69779 |
THP-PEG6-OH CAS:42607-87-4 |
149 |
h |
2024-12-24 |
69780 |
Fmoc-Gly-Gly-Phe-OtBu CAS:236426-37-2 |
91 |
h |
2024-12-24 |
69781 |
5-Gd-DOTA-CS,大环配体 |
83 |
kx |
2024-12-24 |
69782 |
5-(4-乙酰苯胺偶氮)-8-(2,4-二硝基苯)氨基喹啉(AAPDNAQ) |
81 |
WYQ |
2024-12-24 |
69783 |
Ga-DOTA-FAPI/ANCP-PSMA ,镓-大环配体-蛋白抑制剂,大环化合物 |
106 |
kx |
2024-12-24 |
69784 |
Sulfo-DMAC-SPP,663599-11-9,ADC试剂 |
81 |
hyy |
2024-12-24 |
69785 |
Benzyl-PEG5-CH2CO2tBu,苄基-PEG5-乙酸叔丁酯 |
78 |
wyh |
2024-12-24 |
69786 |
地克珠利脂质体,Diclazuril Liposome |
75 |
axc |
2024-12-24 |
69787 |
909024-55-1,DOTA-cyclo(RGDfK) acetate,大环配体 |
72 |
kx |
2024-12-24 |
69788 |
Amino-PEG3-CH2CO2-t-butyl ester,189808-70-6 |
73 |
wyh |
2024-12-24 |
69789 |
叶黄素脂质体,Lutein Liposome |
210 |
axc |
2024-12-24 |
69790 |
齐墩果酸脂质体,Oleanolic Acid Liposome |
120 |
axc |
2024-12-24 |
69791 |
DMAC-SPP,663599-10-8,抗体- 药物偶联物 |
69 |
hyy |
2024-12-24 |
69792 |
DOTA标记的c(RGDfK)环肽,大环化合物 |
72 |
kx |
2024-12-24 |
69793 |
硼替佐米脂质体(聚乙二醇化),Bortezomib Liposome (PEGylated) |
705 |
axc |
2024-12-24 |
69794 |
Cyclooctyne-O-amido-PEG4-PFP ester |
73 |
h |
2024-12-24 |
69795 |
N-(5-Hydroxypentyl)maleimide CAS:180608-78-0 |
68 |
h |
2024-12-24 |